Bleichroeder LP

Q2 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2026
Date filed
8/13/2026
Form type
13F-HR
Num holdings
78
Total value ($000)
$558,938
Net value change ($000)
-19,636 (-3.4%)
New positions
9
Sold out positions
12
Turnover %
6.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
CUE BIOPHARMA INC 11,699 NEW
DUOT 8,367 74.9%
DTIL 6,719 73.5%
SPY 6,523 14.8%
COGT 3,870 NEW
CGEM 3,132 220.4%
KZIA 2,656 89.2%
SPIR 2,511 NEW
NMTC 2,027 NEW
IPWR 1,295 152.5%
Top Reduces (Value $000, Stocks/ETFs)
GLD -29,407 -14.4%
MDXH -13,940 -82.1%
IDN -6,063 -41.8%
RHLD -5,583 -10.9%
GPGI -4,922 -7.3%
INVE -3,404 -31.9%
NMTC -3,106 -100.0%
LIN -2,585 -7.6%
CUE -1,568 -100.0%
POCI -1,189 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type